Skip to main content
Log in

Specificity of heterotrimeric G protein regulation by human chorionic gonadotropin and low-molecular agonist of luteinizing hormone receptor

  • Published:
Cell and Tissue Biology Aims and scope Submit manuscript

Abstract

Luteinizing hormone (LH) and its homologue, human chorionic gonadotropin (hCG), are very important regulators of the reproductive system. These hormones stimulate various types of G proteins—primarily, Gs and Gq proteins—by binding to the specific LH-hCG receptor, which leads to the activation of adenylate cyclase (AC) and phospholipase C, respectively. It has been suggested that many side effects of LH and hCG are associated with low selectivity of their effect on G proteins. Low-molecular agonists of LH-hCG receptor developed on the basis of thienopyrimidine derivatives do not cause these side effects, and differences in the interaction with G proteins may be ones of the cause for this. To test this, a comparative study of the effect of hCG and synthesized by us thienopyrimidine derivative, 5-amino-N-tert-butyl-2-(methylsulfanyl)-4-(3-(nicotinamido)phenyl)thieno[2,3-d]pyrimidine-6-carboxamide (TP03) on the AC activity and GTP binding of G proteins in plasma membranes isolated from the rat ovaries and testes was performed. Cholera toxin (CT) and pertussis toxin (PT) were used to selectively switch off the signal transduction via Gs and Gi/o proteins, the peptide corresponding to the C-terminal segment 349–359 of the Gαq subunit was used to suppress Gq-dependent cascades. It was shown that treatment of ovarian and testicular membranes with CT resulted in suppression of TP03 and hCG stimulatory effects on the AC activity, but in different ways influenced the GTP binding stimulation: it completely blocked the effect of 10–6 M TP03 and reduced by 45–46% the effect of hCG (10–8 M). Preincubation of membranes with the peptide 349–359 reduced the hCG stimulatory effect on GTP binding by 34 (ovaries) and 45% (testes), but did not affect the corresponding effect of 10–6 M TP03. Preincubation with the peptide 349–359 also reduced the GTP stimulatory effect of 10–4 M TP03, but to a small extent. The obtained data indicate that, in contrast to hCG, the targets of which in the ovaries and testes are Gs and Gq proteins, the action of TP03 is realized mainly via Gs proteins. Only at a concentration that exceeds EC50 by two orders TP03 is capable to relatively weakly activate Gq proteins. The PT treatment of the membranes did not affect the effects of TP03 and hCG, which indicates the lack of their effective interaction with Gi/o proteins. Thus, the selectivity of activation of Gs-dependent cascades responsible for the synthesis and production of steroid hormones is a significant advantage of low-molecular agonists of LH-hCG receptor over gonadotropins.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

AC:

adenylate cyclase

PT:

pertussis toxin

LH:

luteinizing hormone

hCG:

human chorionic gonadotropin

CT:

cholera toxin

GppNHp:

β,γ-imidoguanosine-5'-triphosphate

TP03:

5-amino-N-tert-butyl-2-(methylsulfanyl)-4-(3-(nicotinamido)phenyl)thieno[2,3-d]pyrimidine-6-carboxamide

VEGF:

vascular endothelial growth factor

References

  • Bakhtyukov, A.A. and Shpakov, A.O., The molecular mechanisms of steroidogenesis regulation in Leydig cells, Tsitologiia, 2016, vol. 58, no. 9, pp. 666–678.

    Google Scholar 

  • Casarini, L., Reiter, E., and Simoni, M., B-arrestins regulate gonadotropin receptor-mediated cell proliferation and apoptosis by controlling different FSHR or LHCGR intracellular signaling in the hGL5 cell line, Mol. Cell. Endocrinol., 2016, vol. 437, pp. 11–21.

    Article  CAS  PubMed  Google Scholar 

  • Chillar, A., Wu, J., Cervantes, V., and Ruan, K.H., Structural and functional analysis of the C-terminus of Gαq in complex with the human thromboxane A2 receptor provides evidence of constitutive activity, Biochemistry, 2010, vol. 49, pp. 6365–6374.

    Article  CAS  PubMed  Google Scholar 

  • Derkach, K.V., Dar’in, D.V., Lobanov, P.S., and Shpakov, A.O., Intratesticular, intraperitoneal, and oral administration of thienopyrimidine derivatives increases the testosterone level in male rats, Dokl. Biol. Sci., 2014, vol. 459, no. 1, pp. 326–329.

    Article  CAS  PubMed  Google Scholar 

  • Derkach, K.V., Bondareva, V.M., Chistyakova, O.V., Berstein, L.M., and Shpakov, A.O., The effect of long-term intranasal serotonin treatment on metabolic parameters and hormonal signaling in rats with high-fat diet/low-dose streptozotocin-induced type 2 diabetes, Int. J. Endocrinol., 2015, vol. 2015, pp. 245459.

    Article  PubMed  PubMed Central  Google Scholar 

  • Derkach, K.V., Dar’in, D.V., Bakhtyukov, A.A., Lobanov, P.S., and Shpakov, A.O., In vitro and in vivo studies of functional activity of new low molecular weight agonists of the luteinizing hormone receptor, Biochemistry (Moscow). Suppl. Ser. A: Membr. Cell Biol., 2016, vol. 10, no. 4, pp. 294–300.

    Article  Google Scholar 

  • Gerrits, M., Mannaerts, B., Kramer, H., Addo, S., and Hanssen, R., First evidence of ovulation induced by oral LH agonists in healthy female volunteers of reproductive age, J. Clin. Endocrinol. Metab., 2013, vol. 98, pp. 1558–1566.

    Article  CAS  PubMed  Google Scholar 

  • Gilchrist, R.L., Ryu, K.S., Ji, I., and Ji, T.H., The luteinizing hormone/chorionic gonadotropin receptor has distinct transmembrane conductors for cAMP and inositol phosphate signals, J. Biol. Chem., 1996, vol. 271, pp. 19283–19287.

    Article  CAS  PubMed  Google Scholar 

  • Gudermann, T., Kalkbrenner, F., and Schultz, G., Diversity and selectivity of receptor–G protein interaction, Annu. Rev. Pharmacol. Toxicol., 1996, vol. 36, pp. 429–460.

    Article  CAS  PubMed  Google Scholar 

  • Heitman, L.H., and Ijzerman, A.P., G protein-coupled receptors of the hypothalamic-pituitary-gonadal axis: a case for Gnrh, LH, FSH, and GPR54 receptor ligands, Med. Res. Rev., 2008, vol. 28, pp. 975–1011.

    Article  CAS  PubMed  Google Scholar 

  • Jiang, X., Dias, J.A., and He, X., Structural biology of glycoprotein hormones and their receptors: insights to signaling, Mol. Cell. Endocrinol., 2014, vol. 382, pp. 424–451.

    Article  CAS  PubMed  Google Scholar 

  • Kleinau, G. and Krause, G., Thyrotropin and homologous glycoprotein hormone receptors: structural and functional aspects of extracellular signaling mechanisms, Endocr. Rev., 2009, vol. 30, pp. 133–151.

    Article  CAS  PubMed  Google Scholar 

  • Nataraja, S.G., Yu, H.N., and Palmer, S.S., Discovery and development of small molecule allosteric modulators of glycoprotein hormone receptors, Front. Endocrinol. (Lausanne), 2015, vol. 6, p. 142.

    Google Scholar 

  • Puett, D., Li, Y., DeMars, G., Angelova, K., and Fanelli, F., A functional transmembrane complex: the luteinizing hormone receptor with bound ligand and G protein, Mol. Cell. Endocrinol., 2007, vol. 260, pp. 126–136.

    Article  PubMed  Google Scholar 

  • Shpakov, A.O., New achievements in the development and study of the mechanisms of action of the low molecular weight agonists of receptors of the thyroid-stimulating and the luteinizing hormones, Tsitologiya, 2015, vol. 57, no. 3, pp. 167–176.

    CAS  Google Scholar 

  • Shpakov, A.O., Shpakova, E.A., Tarasenko, I.I., Derkach, K.V., and Vlasov, G.P., The peptides mimicking the third intracellular loop of 5-hydroxytryptamine receptors of the types 1B and 6 selectively activate G proteins and receptor-specifically inhibit serotonin signaling via the adenylyl cyclase system, Int. J. Pept. Res. Ther., 2010, vol. 16, pp. 95–105.

    Article  CAS  Google Scholar 

  • Shpakov, A.O., Dar’in, D.V., Derkach, K.V., and Lobanov, P.S., The stimulating influence of thienopyrimidine compounds on the adenylyl cyclase systems in the rat testes, Dokl. Biochem. Biophys., 2014a, vol. 456, no. 1, pp. 104–107.

    Article  CAS  PubMed  Google Scholar 

  • Shpakov, A.O., Derkach, K.V., Dar’in, D.V., and Lobanov, P.S., Activation of adenylyl cyclase by thienopyrimidine derivatives in rat testes and ovaries, Cell Tissue Biol., 2014b, vol. 8, no. 5, pp. 400–406.

    Article  Google Scholar 

  • Sivaraj, K.K., Li, R., Albarran-Juarez, J., Wang, S., Tischner, D., Grimm, M., Swiercz, J.M., Offermanns, S., and Wettschureck, N., Endothelial Gαq/11 is required for VEGF-induced vascular permeability and angiogenesis, Cardiovasc. Res., 2015, vol. 108, pp. 171–180.

    Article  CAS  PubMed  Google Scholar 

  • Szkudlinski, M.W., New frontier in glycoprotein hormones and their receptors structure–function, Front. Endocrinol. (Lausanne), 2015, vol. 6, p. 155.

    Google Scholar 

  • Troppmann, B., Kleinau, G., Krause, G., and Gromoll, J., Structural and functional plasticity of the luteinizing hormone/ choriogonadotrophin receptor, Hum. Reprod. Update, 2013, vol. 19, pp. 583–602.

    Article  CAS  PubMed  Google Scholar 

  • van de Lagemaat, R., Raafs, B.C., van Koppen, C., Timmers, C.M., Mulders, S.M., and Hanssen, R.G., Prevention of the onset of ovarian hyperstimulation syndrome (OHSS) in the rat after ovulation induction with a low molecular weight agonist of the LH receptor compared with hCG and Rec-LH, Endocrinology, 2011, vol. 152, pp. 4350–4357.

    Article  PubMed  Google Scholar 

  • van de Lagemaat, R., Timmers, C.M., Kelder, J., van Koppen, C., Mosselman, S., and Hanssen, R.G., Induction of ovulation by a potent, orally active, low molecular weight agonist (Org 43553) of the luteinizing hormone receptor, Hum. Reprod., 2009, vol. 24, pp. 640–648.

    Article  PubMed  Google Scholar 

  • van Koppen, C.J., Zaman, G.J., Timmers, C.M., Kelder, J., Mosselman, S., van de Lagemaat, R., Smit, M.J., and Hanssen, R.G., A signaling-selective, nanomolar potent allosteric low molecular weight agonist for the human luteinizing hormone receptor, Naunyn Schmiedebergs Arch. Pharmacol., 2008, vol. 378, pp. 503–514.

    Article  PubMed  Google Scholar 

  • Zeng, H., Zhao, D., Yang, S., Datta, K., and Mukhopadhyay, D., Heterotrimeric Gαq/Gα11 proteins function upstream of vascular endothelial growth factor (VEGF) receptor-2 (KDR) phosphorylation in vascular permeability factor/VEGF signaling, J. Biol. Chem., 2003, vol. 278, pp. 20738–20745.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. O. Shpakov.

Additional information

Original Russian Text © K.V. Derkach, A.A. Bakhtyukov, A.A. Shpakov, D.V. Dar’in, A.O. Shpakov, 2017, published in Tsitologiya, 2017, Vol. 59, No. 7, pp. 474–481.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Derkach, K.V., Bakhtyukov, A.A., Shpakov, A.A. et al. Specificity of heterotrimeric G protein regulation by human chorionic gonadotropin and low-molecular agonist of luteinizing hormone receptor. Cell Tiss. Biol. 11, 475–482 (2017). https://doi.org/10.1134/S1990519X17060037

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S1990519X17060037

Keywords

Navigation